This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Investigations

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The following tests/procedures are carried out as the initial work up of a patient with AML:

Tests required to establish the diagnosis include:

  • complete blood counts and differential count
  • bone marrow aspirate - marrow blast count of 20% or more is required
  • immunophenotyping
  • cytogenetics

Additional tests/procedures which are carried out at diagnosis are:

  • demographics and medical history
  • performance status (ECOG/WHO score)
  • analysis of comorbidities
  • biochemistry - glucose, sodium, potassium, calcium, creatinine, aspartate amino transferase (AST), alanine amino transferase (ALT), alkaline phosphatase, lactate dehydrogenase, bilirubin, urea, total protein, uric acid
  • coagulation tests - prothrombin time (PTT), international normalized ratio (INR) if indicated, activated partial thromboplastin time (aPTT).
  • urine analysis - pH, glucose, erythrocytes, leukocytes, protein, nitrite.
  • serum pregnancy test - in women of childbearing age
  • hepatitis A, B, C; HIV-1 testing
  • chest x-ray, 12-lead ECG; echocardiography (if indicated)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.